Early Access

10-KPeriod: FY2024

ALTRIA GROUP, INC. Annual Report, Year Ended Dec 31, 2024

Filed February 26, 2025For Securities:MO

Summary

Altria Group, Inc. reported robust financial performance for the fiscal year ending December 31, 2024, with reported net earnings of $11.26 billion, a significant increase from $8.13 billion in the prior year. This growth was driven by substantial gains from the sale of the IQOS System commercialization rights, favorable tax items, and positive contributions from equity investments, which largely offset a decrease in operating income. The company's "Moving Beyond Smoking" strategy continues to guide its transition towards smoke-free products. Despite a 10.2% decline in cigarette shipment volume for PM USA and a 1.5% decline in cigar shipments, Altria demonstrated pricing power and cost management, with adjusted diluted EPS increasing by 3.4% year-over-year. The company also advanced its commitment to returning capital to shareholders through substantial share repurchases and a progressive dividend policy. The company faces ongoing challenges including evolving consumer preferences, the proliferation of illicit flavored e-vapor products, and a dynamic regulatory landscape. However, Altria remains focused on its long-term goals, including growing its U.S. smoke-free portfolio and exploring opportunities in new categories. The acquisition of NJOY has been integrated, and while it incurred net pre-tax expenses related to the transaction, it represents a strategic step in expanding Altria's e-vapor offerings. The company's financial position remains solid, supported by substantial cash and cash equivalents and credit facilities, enabling continued investment in its strategic priorities and shareholder returns.

Financial Statements
Beta

Key Highlights

  • 1Altria reported a significant increase in reported net earnings to $11.26 billion for the fiscal year 2024, up from $8.13 billion in 2023, largely due to a $2.7 billion pre-tax gain from the sale of IQOS System commercialization rights.
  • 2Adjusted diluted EPS saw a modest increase of 3.4% to $5.12 in 2024, demonstrating resilience despite a challenging operating environment.
  • 3The company completed its $3.4 billion share repurchase program in December 2024 and authorized a new $1.0 billion program for 2025, underscoring its commitment to shareholder returns.
  • 4Cigarette shipment volumes declined by 10.2% for PM USA, reflecting industry-wide volume declines and consumer shifts, but pricing actions helped offset some of this impact.
  • 5The oral tobacco products segment saw net revenue increase by 4.1% and adjusted OCI grow by 5.2%, driven by higher pricing, though volumes declined slightly.
  • 6Altria is actively managing its investment portfolio, having completed the sale of a portion of its Anheuser-Busch InBev (ABI) investment and continuing to account for its investment in Cronos Group under the equity method.
  • 7The company is facing significant headwinds in the e-vapor category due to the proliferation of illicit flavored disposable e-vapor products, which have impacted NJOY's performance and led to an impairment assessment of related goodwill and intangible assets.

Frequently Asked Questions